So this is a really interesting question, one that the researchers who conducted the first two clinical trials of exenatide in Parkinsons wanted to investigate
For 2025, the focus has moved even further toward individualized, outcomes-driven care, emphasizing early combination therapy, cardiovascular risk management, and digital health integration
It helps many patients eat less, improve blood sugar control, and lose significant weight (Reference)
Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits
Dapagliflozin And Metformin (Oral Route)
Its clinical application is no longer confined to hypoglycemic reduction, and the types of GLP-1RA used in clinical applications are also increasingly more diverse